DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing
DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing
批准号:
8525116
负责人:
MICHAEL T MCMAHON
金额:
$32.83万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-22 至 2015-08-31
关键词:
Acute Liver FailureAlginatesAmino AcidsAntibodiesApoptosisArginineAttentionBiocompatibleCell LineCell SurvivalCell TherapyCell physiologyCellsChemicalsClinicClinicalColorContrast MediaCrosslinkerDetectionDiabetic mouseDiscriminationDiseaseEncapsulatedEnvironmentFirefly LuciferasesGoalsHemophilia AHumanImageImageryIn VitroIndividualInsulinInsulin-Dependent Diabetes MellitusIslet CellIslets of LangerhansIslets of Langerhans TransplantationLabelLibrariesLifeLipidsLiposomesMagnetic ResonanceMagnetic Resonance ImagingMalignant NeoplasmsMeasuresMembraneMesenchymalMesenchymal Stem CellsMetalsMethodsMicroencapsulationsMonitorMusParkinson DiseasePatientsPeptidesPhysiologicalPopulationProductionReportingSignal TransductionSourceStagingStem cellsStreptozocinTechniquesTestingTherapeutic immunosuppressionTimeToxic effectTreatment ProtocolsValidationbasecapsulecell capsuledesignfunctional statusglycemic controlin vivoinsulin secretioninsulinomaisletmouse modelpre-clinicalpreclinical studypreventpublic health relevanceremote sensingsmall molecule librariessuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Good glycemic control is critical in reducing the end-stage complications of Type I Diabetes Mellitus (TIDM) and, for this reason, islet transplantation (ITx) has received considerable attention in recent years, with one of the complications in the treatment involves finding an effective means to prevent rejection. Immuno-isolation of islets provides a means to reduce or avoid immunosuppressive therapy altogether. In the most commonly used method of immuno-isolation, microencapsulation, individual islets are surrounded with thin alginate membranes that are permeable to insulin and metabolites, but are impermeable to native antibodies. However, the viability and in particular the insulin secretion of these islets are critical for the success of the therapy, and would be important to monitor for refinement of the treatment protocol. This proposal is focused on the production of micron sized CEST MR detectable alginate capsules containing both islet and mesenchymal stem cells which are appropriate for the treatment of T1DM. These capsules will have CEST MR contrast agents built into the capsule to allow: 1) detection, 2) discrimination between encapsulated islet and mesynchymal stem cells and 3) remote sensing of the pH of the environment. The source of the CEST contrast will be 6-24 amino acid long peptides and CEST liposomes embedded within the alginate. We will perform pre-clinical studies using a nude based mouse model of diabetes to allow monitoring of the status of encapsulated islets/ mesenchymal cells through firefly luciferase expression.
PUBLIC HEALTH RELEVANCE: Islet transplantation (ITx) has received considerable attention in recent years for treatment of Type 1 Diabetes Melitus (T1DM). This proposal is focused on the production of immunoprotective islet cell capsules which are appropriate for treatment and allow MR monitoring of the pH these islets using biodegradable CEST contrast agents.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Screening of CEST MR contrast agents.
CEST MR 造影剂的筛选。
DOI:
10.1007/978-1-61779-219-9_9
发表时间:
2011
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
[Song,Xiaolei, Chan,KannieWY, McMahon,MichaelT]
通讯作者:
McMahon,MichaelT
DOI:
10.1021/ja403542g
发表时间:
2013-08-21
期刊:
Journal of the American Chemical Society
影响因子:
15
作者:
[Bar-Shir A, Gilad AA, Chan KW, Liu G, van Zijl PC, Bulte JW, McMahon MT]
通讯作者:
McMahon MT
DOI:
10.1021/ja511313k
发表时间:
2015-01-14
期刊:
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
影响因子:
15
作者:
[Bar-Shir, Amnon, Yadav, Nirbhay N., Gilad, Assaf A., van Zijl, Peter C. M., McMahon, Michael T., Bulte, Jeff W. M.]
通讯作者:
Bulte, Jeff W. M.
DOI:
10.1002/wnan.1246
发表时间:
2014-01
期刊:
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY
影响因子:
8.6
作者:
[Chan, Kannie W. Y., Bulte, Jeff W. M., McMahon, Michael T.]
通讯作者:
McMahon, Michael T.
DOI:
10.1002/nbm.2899
发表时间:
2013-07
期刊:
NMR IN BIOMEDICINE
影响因子:
2.9
作者:
[Liu, Guanshu, Song, Xiaolei, Chan, Kannie W. Y., McMahon, Michael T.]
通讯作者:
McMahon, Michael T.
共 6 条
Developing MRI contrast agents to detect progression in renal disease as a consequence of acidema
-
批准号:10551303
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2020
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Developing MRI contrast agents to detect progression in renal disease as a consequence of acidema
-
批准号:10337274
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2020
-
负责人:MICHAEL T MCMAHON
-
依托单位:
CEST MRI Agents for Receptor Imaging
-
批准号:10226212
-
项目类别:
-
资助金额:$25.66万
-
财政年份:2017
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Multi-Color Exchange Transfer Imaging of Drug Delivery Nanocarriers
-
批准号:8479358
-
项目类别:
-
资助金额:$57.81万
-
财政年份:2011
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Multi-Color Exchange Transfer Imaging of Drug Delivery Nanocarriers
-
批准号:8292578
-
项目类别:
-
资助金额:$61.89万
-
财政年份:2011
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Multi-Color Exchange Transfer Imaging of Drug Delivery Nanocarriers
-
批准号:8677891
-
项目类别:
-
资助金额:$56.52万
-
财政年份:2011
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Multi-Color Exchange Transfer Imaging of Drug Delivery Nanocarriers
-
批准号:8305994
-
项目类别:
-
资助金额:$60.96万
-
财政年份:2011
-
负责人:MICHAEL T MCMAHON
-
依托单位:
DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing
-
批准号:8023872
-
项目类别:
-
资助金额:$33.12万
-
财政年份:2010
-
负责人:MICHAEL T MCMAHON
-
依托单位:
DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing
-
批准号:8323997
-
项目类别:
-
资助金额:$34.82万
-
财政年份:2010
-
负责人:MICHAEL T MCMAHON
-
依托单位:
DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing
-
批准号:8146032
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2010
-
负责人:MICHAEL T MCMAHON
-
依托单位:
16.4T Vertical Wide Bore Animal MR Imager
-
批准号:7498705
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2009
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking
-
批准号:7448639
-
项目类别:
-
资助金额:$12.45万
-
财政年份:2006
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking
-
批准号:7130476
-
项目类别:
-
资助金额:$11.59万
-
财政年份:2006
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking
-
批准号:7265096
-
项目类别:
-
资助金额:$11.81万
-
财政年份:2006
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking
-
批准号:7667850
-
项目类别:
-
资助金额:$12.82万
-
财政年份:2006
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking
-
批准号:7912901
-
项目类别:
-
资助金额:$13.2万
-
财政年份:2006
-
负责人:MICHAEL T MCMAHON
-
依托单位:
A SOLID STATE NMR INVESTIGATION OF BACTERIORHODOPSIN
-
批准号:6518893
-
项目类别:
-
资助金额:$4.42万
-
财政年份:2001
-
负责人:MICHAEL T MCMAHON
-
依托单位:
A SOLID STATE NMR INVESTIGATION OF BACTERIORHODOPSIN
-
批准号:6294279
-
项目类别:
-
资助金额:$3.48万
-
财政年份:2001
-
负责人:MICHAEL T MCMAHON
-
依托单位:
CEST MRI Agents for Receptor Imaging
-
批准号:9984374
-
项目类别:
-
资助金额:$31.04万
-
财政年份:--
-
负责人:MICHAEL T MCMAHON
-
依托单位:
CEST MRI Agents for Receptor Imaging
-
批准号:9358163
-
项目类别:
-
资助金额:$27.62万
-
财政年份:--
-
负责人:MICHAEL T MCMAHON
-
依托单位:
海外基金